450 related articles for article (PubMed ID: 15279638)
1. Pleomorphic adenoma and carcinoma ex pleomorphic adenoma: immunohistochemical demonstration of the association between tenascin expression and malignancy.
Félix A; Rosa JC; Fonseca I; Cidadão A; Soares J
Histopathology; 2004 Aug; 45(2):187-92. PubMed ID: 15279638
[TBL] [Abstract][Full Text] [Related]
2. Peroxiredoxin I, platelet-derived growth factor A, and platelet-derived growth factor receptor alpha are overexpressed in carcinoma ex pleomorphic adenoma: association with malignant transformation.
Demasi AP; Furuse C; Soares AB; Altemani A; Araújo VC
Hum Pathol; 2009 Mar; 40(3):390-7. PubMed ID: 18992915
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical expression of p63 in pleomorphic adenomas and carcinomas ex-pleomorphic adenomas of salivary glands.
Genelhu MC; Gobbi H; Soares FA; Campos AH; Ribeiro CA; Cassali GD
Oral Oncol; 2006 Feb; 42(2):154-60. PubMed ID: 16256413
[TBL] [Abstract][Full Text] [Related]
4. Laminin and collagen IV in pleomorphic adenoma and carcinoma ex-pleomorphic adenoma: an immunohistochemical study.
Félix A; Rosa JC; Fonseca I; Cidadão A; Soares J
Hum Pathol; 1999 Aug; 30(8):964-9. PubMed ID: 10452510
[TBL] [Abstract][Full Text] [Related]
5. An intracapsular carcinoma ex pleomorphic adenoma with lung metastases composed exclusively of benign elements: histological evidence of a continuum between metastasizing pleomorphic adenoma and carcinoma ex pleomorphic adenoma.
Weissferdt A; Langman G
Pathol Res Pract; 2010 Jul; 206(7):480-3. PubMed ID: 19665316
[TBL] [Abstract][Full Text] [Related]
6. An immunohistochemical study of XIAP expression in pleomorphic adenoma and carcinoma ex pleomorphic adenoma.
Hoch BL; Wu M; Lewis M; Gan L; Burstein DE
J Oral Pathol Med; 2008 Nov; 37(10):634-8. PubMed ID: 18673415
[TBL] [Abstract][Full Text] [Related]
7. Non-invasive (intracapsular) carcinoma ex pleomorphic adenoma: recognition of focal carcinoma by HER-2/neu and MIB1 immunohistochemistry.
Di Palma S; Skálová A; Vanìèek T; Simpson RH; Stárek I; Leivo I
Histopathology; 2005 Feb; 46(2):144-52. PubMed ID: 15693886
[TBL] [Abstract][Full Text] [Related]
8. Expression of Mcm-2, Ki-67 and geminin in benign and malignant salivary gland tumours.
Vargas PA; Cheng Y; Barrett AW; Craig GT; Speight PM
J Oral Pathol Med; 2008 May; 37(5):309-18. PubMed ID: 18248354
[TBL] [Abstract][Full Text] [Related]
9. Expression of betacatenin in carcinoma in pleomorphic adenoma, pleomorphic adenoma and normal salivary gland: an immunohistochemical study.
do Prado RF; Consolaro A; Taveira LA
Med Oral Patol Oral Cir Bucal; 2006 May; 11(3):E247-51. PubMed ID: 16648762
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of cyclooxygenase-2 and Ki-67 are associated with malignant transformation of pleomorphic adenoma.
Katori H; Nozawa A; Tsukuda M
Auris Nasus Larynx; 2007 Mar; 34(1):79-84. PubMed ID: 17049779
[TBL] [Abstract][Full Text] [Related]
11. Expression of epidermal growth factor receptor, transforming growth factor-alpha and Ki-67 in relationship to malignant transformation of pleomorphic adenoma.
Katori H; Nozawa A; Tsukuda M
Acta Otolaryngol; 2007 Nov; 127(11):1207-13. PubMed ID: 17851915
[TBL] [Abstract][Full Text] [Related]
12. Metastatic benign pleomorphic adenoma. Report of a case and review of the literature.
Rodríguez-Fernández J; Mateos-Micas M; Martínez-Tello FJ; Berjón J; Montalvo JJ; Forteza-González G; Galan-Hernández R
Med Oral Patol Oral Cir Bucal; 2008 Mar; 13(3):E193-6. PubMed ID: 18305442
[TBL] [Abstract][Full Text] [Related]
13. Immunoprofile of reactive salivary myoepithelial cells in intraductal areas of carcinoma ex-pleomorphic adenoma.
de Araújo VC; Altemani A; Furuse C; Martins MT; de Araújo NS
Oral Oncol; 2006 Nov; 42(10):1011-6. PubMed ID: 16757205
[TBL] [Abstract][Full Text] [Related]
14. Intraductal carcinoma is the precursor of carcinoma ex pleomorphic adenoma and is often associated with dysfunctional p53.
Ihrler S; Weiler C; Hirschmann A; Sendelhofert A; Lang S; Guntinas-Lichius O; Arnold G; Zietz C; Harrison JD
Histopathology; 2007 Sep; 51(3):362-71. PubMed ID: 17593217
[TBL] [Abstract][Full Text] [Related]
15. Carcinoma ex pleomorphic adenoma (CXPA): immunoprofile of the cells involved in carcinomatous progression.
Altemani A; Martins MT; Freitas L; Soares F; Araújo NS; Araújo VC
Histopathology; 2005 Jun; 46(6):635-41. PubMed ID: 15910594
[TBL] [Abstract][Full Text] [Related]
16. [A case of very late malignant degeneration of pleomorphic adenoma].
Darche V; Hustin J; Lejuste P; Robillard T; Piette E
Ann Otolaryngol Chir Cervicofac; 1998 Dec; 115(6):373-7. PubMed ID: 9922836
[TBL] [Abstract][Full Text] [Related]
17. [The expression of matrix metalloproteinases and their tissue inhibitors in pleomorphic adenoma].
Chen Y; Tian K; Geng N; Yang MZ; Zhang WP
Zhonghua Kou Qiang Yi Xue Za Zhi; 2005 Jan; 40(1):58-61. PubMed ID: 15774155
[TBL] [Abstract][Full Text] [Related]
18. Immunolocalization of three novel smooth muscle-specific proteins in salivary gland pleomorphic adenoma: assessment of the morphogenetic role of myoepithelium.
Savera AT; Gown AM; Zarbo RJ
Mod Pathol; 1997 Nov; 10(11):1093-100. PubMed ID: 9388059
[TBL] [Abstract][Full Text] [Related]
19. Beta-6 Integrin, tenascin-C, and MMP-1 expression in salivary gland neoplasms.
Westernoff TH; Jordan RC; Regezi JA; Ramos DM; Schmidt BL
Oral Oncol; 2005 Feb; 41(2):170-4. PubMed ID: 15695119
[TBL] [Abstract][Full Text] [Related]
20. Increased mucin 1 expression in recurrence and malignant transformation of salivary gland pleomorphic adenoma.
Soares AB; Demasi AP; Altemani A; de Araújo VC
Histopathology; 2011 Feb; 58(3):377-82. PubMed ID: 21323961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]